This new lipid nanoparticle production system developed by Shin-Etsu Chemical and Hokkaido University is capable of small-batch and mass production ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Verve Therapeutics said Monday that initial data show that its investigational gene-editing therapy lowered cholesterol ...

Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach and enhance results.

The raise will go toward trialing the company’s lead drug for phosphomannomutase-2 congenital disorder of glycosylation, a ...

Abstract: In one important chemical engineering unit operation of messenger ribonucleic acid (mRNA) vaccine manufacture, the precious mRNA payload is encapsulated in lipid nanoparticles. Recent ...

Wall Street analysts said the results for Verve’s therapy appeared competitive on efficacy, while avoiding any major safety ...

The Boston-based company said its gene-editing treatment for people with high cholesterol was well-tolerated with no serious ...